Prelude Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,490
| Closed | -$43K | – | 1305 |
|
|
2020
Q1 | $43K | Sell |
1,490
-2,332
| -61% | -$67.3K | ﹤0.01% | 504 |
|
|
2019
Q4 | $198K | Buy |
+3,822
| New | +$198K | 0.01% | 538 |
|
|
2019
Q1 | – | Sell |
-4,865
| Closed | -$164K | – | 1335 |
|
|
2018
Q4 | $164K | Buy |
+4,865
| New | +$164K | 0.01% | 557 |
|
|
2018
Q3 | – | Sell |
-3,207
| Closed | -$103K | – | 1346 |
|
|
2018
Q2 | $103K | Buy |
+3,207
| New | +$103K | 0.01% | 709 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1201 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1468 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1462 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1416 |
|
|
2016
Q4 | – | Sell |
-1,067
| Closed | -$51K | – | 1477 |
|
|
2016
Q3 | $51K | Buy |
+1,067
| New | +$51K | 0.01% | 968 |
|
|
2015
Q2 | – | Sell |
-4,600
| Closed | -$189K | – | 1573 |
|
|
2015
Q1 | $189K | Buy |
+4,600
| New | +$189K | 0.03% | 651 |
|
|
2014
Q3 | – | Sell |
-2,769
| Closed | -$128K | – | 1723 |
|
|
2014
Q2 | $128K | Buy |
2,769
+800
| +41% | +$37K | 0.02% | 879 |
|
|
2014
Q1 | $81K | Buy |
+1,969
| New | +$81K | 0.01% | 972 |
|